Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in SCLX — Scilex Holding Co

CIK 72971 SAN FRANCISCO, CA
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$499
+$41 QoQ
Shares Held
64
-42.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 72 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,646,119 $5,572,694,974
2 JNJ
Johnson & Johnson
 17,374,433 $4,412,584,747
3 AMGN
Amgen Inc
 7,235,462 $2,620,105,497
4 ABBV
AbbVie Inc.
 9,017,580 $2,269,183,828
5 MRK
Merck & Co., Inc.
 11,658,434 $1,498,108,767
6 GILD
Gilead Sciences, Inc.
 6,439,586 $813,577,293
7 PFE
Pfizer Inc
 20,193,675 $486,263,691
8 BMY
Bristol Myers Squibb Co
 6,321,643 $364,253,067

All Filings in SCLX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $499 64
2026-03-31 $458 69
2025-12-31 $1,475 121
2025-09-30 $2,026 103
2025-06-30 $1,530 260
2024-09-30 $83 90
2024-06-30 $1,908 989
2024-03-31 $2,677 1,684
2023-12-31 $3,389 1,662
2023-09-30 $2,252 1,609
2023-06-30 $5,508 989
2023-03-31 $8,109 989